Incidence of cancers in patients with atherosclerotic cardiovascular diseases

Background: To address a clinical impact of atherosclerotic cardiovascular diseases (CVD) on cancer developments, we investigated an issue whether any difference in an incidence of cancers is present between patients with atherosclerotic CVD and those with non-atherosclerotic CVD. Methods: Of a tota...

Full description

Bibliographic Details
Main Authors: Makoto Suzuki, Hitonobu Tomoike, Tetsuya Sumiyoshi, Yuji Nagatomo, Toru Hosoda, Masatoshi Nagayama, Yuichi Ishikawa, Tomohiro Sawa, Satoshi Iimuro, Tsutomu Yoshikawa, Saichi Hosoda
Format: Article
Language:English
Published: Elsevier 2017-12-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906717300453
_version_ 1811240005127897088
author Makoto Suzuki
Hitonobu Tomoike
Tetsuya Sumiyoshi
Yuji Nagatomo
Toru Hosoda
Masatoshi Nagayama
Yuichi Ishikawa
Tomohiro Sawa
Satoshi Iimuro
Tsutomu Yoshikawa
Saichi Hosoda
author_facet Makoto Suzuki
Hitonobu Tomoike
Tetsuya Sumiyoshi
Yuji Nagatomo
Toru Hosoda
Masatoshi Nagayama
Yuichi Ishikawa
Tomohiro Sawa
Satoshi Iimuro
Tsutomu Yoshikawa
Saichi Hosoda
author_sort Makoto Suzuki
collection DOAJ
description Background: To address a clinical impact of atherosclerotic cardiovascular diseases (CVD) on cancer developments, we investigated an issue whether any difference in an incidence of cancers is present between patients with atherosclerotic CVD and those with non-atherosclerotic CVD. Methods: Of a total of 32,095 consecutive patients with acquired CVD enrolled in the Sakakibara Health Integrative Profile cohort study, we segregated patients based on a presence of atherosclerotic or non-atherosclerotic CVD to investigate an incidence of cancers and mortality. We also evaluated an incidence of cancers in patients with a singular presence versus a plural presence of atherosclerotic CVD. Atherosclerotic CVD included coronary artery diseases, aortic diseases and peripheral artery diseases. Non-atherosclerotic CVD were any acquired CVD except atherosclerotic CVD. Results: During a median follow-up of 1020 days (interquartile range, 665–1340 days), an incidence of cancers (5% vs. 2%, p = 0.0001) and overall mortality (6% vs. 3%, p = 0.0001) were more than two-fold higher in 10,592 patients with atherosclerotic CVD than in 21,503 patients with non-atherosclerotic CVD. A presence of atherosclerotic CVD (hazard ratio 1.372 with 95% confidence interval 1.199–1.569) was independently associated with an incidence of cancers. In patients with atherosclerotic CVD, 61 of 640 patients with a plural presence and 470 of 9932 patients with a singular presence developed cancers (9% vs. 5%, p = 0.0001). An incremental risk of death was found according to a presence of atherosclerotic CVD, cancers, and both of them (all p = 0.0001). Conclusions: A presence of atherosclerotic CVD itself may have a potential risk for cancer developments. Trial registration: ClinicalTrials.gov. number, NCT03005834
first_indexed 2024-04-12T13:11:41Z
format Article
id doaj.art-409a714863f34ad6aa8acad22dfec484
institution Directory Open Access Journal
issn 2352-9067
language English
last_indexed 2024-04-12T13:11:41Z
publishDate 2017-12-01
publisher Elsevier
record_format Article
series International Journal of Cardiology: Heart & Vasculature
spelling doaj.art-409a714863f34ad6aa8acad22dfec4842022-12-22T03:31:50ZengElsevierInternational Journal of Cardiology: Heart & Vasculature2352-90672017-12-0117C111610.1016/j.ijcha.2017.08.004Incidence of cancers in patients with atherosclerotic cardiovascular diseasesMakoto Suzuki0Hitonobu Tomoike1Tetsuya Sumiyoshi2Yuji Nagatomo3Toru Hosoda4Masatoshi Nagayama5Yuichi Ishikawa6Tomohiro Sawa7Satoshi Iimuro8Tsutomu Yoshikawa9Saichi Hosoda10Department of Cardiology, Sakakibara Heart Institute, Tokyo, JapanDepartment of Cardiology, Sakakibara Heart Institute, Tokyo, JapanDepartment of Cardiology, Sakakibara Heart Institute, Tokyo, JapanDepartment of Cardiology, Sakakibara Heart Institute, Tokyo, JapanDepartment of Cardiology, Sakakibara Heart Institute, Tokyo, JapanDepartment of Cardiology, Sakakibara Heart Institute, Tokyo, JapanDivision of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, JapanMedical Information and System Research Center, Teikyo University, Tokyo, JapanTeikyo Academic Research Center, Teikyo University, Tokyo, JapanDepartment of Cardiology, Sakakibara Heart Institute, Tokyo, JapanDepartment of Cardiology, Sakakibara Heart Institute, Tokyo, JapanBackground: To address a clinical impact of atherosclerotic cardiovascular diseases (CVD) on cancer developments, we investigated an issue whether any difference in an incidence of cancers is present between patients with atherosclerotic CVD and those with non-atherosclerotic CVD. Methods: Of a total of 32,095 consecutive patients with acquired CVD enrolled in the Sakakibara Health Integrative Profile cohort study, we segregated patients based on a presence of atherosclerotic or non-atherosclerotic CVD to investigate an incidence of cancers and mortality. We also evaluated an incidence of cancers in patients with a singular presence versus a plural presence of atherosclerotic CVD. Atherosclerotic CVD included coronary artery diseases, aortic diseases and peripheral artery diseases. Non-atherosclerotic CVD were any acquired CVD except atherosclerotic CVD. Results: During a median follow-up of 1020 days (interquartile range, 665–1340 days), an incidence of cancers (5% vs. 2%, p = 0.0001) and overall mortality (6% vs. 3%, p = 0.0001) were more than two-fold higher in 10,592 patients with atherosclerotic CVD than in 21,503 patients with non-atherosclerotic CVD. A presence of atherosclerotic CVD (hazard ratio 1.372 with 95% confidence interval 1.199–1.569) was independently associated with an incidence of cancers. In patients with atherosclerotic CVD, 61 of 640 patients with a plural presence and 470 of 9932 patients with a singular presence developed cancers (9% vs. 5%, p = 0.0001). An incremental risk of death was found according to a presence of atherosclerotic CVD, cancers, and both of them (all p = 0.0001). Conclusions: A presence of atherosclerotic CVD itself may have a potential risk for cancer developments. Trial registration: ClinicalTrials.gov. number, NCT03005834http://www.sciencedirect.com/science/article/pii/S2352906717300453Atherosclerotic cardiovascular diseasesCancersMortalityThe SHIP cohort study
spellingShingle Makoto Suzuki
Hitonobu Tomoike
Tetsuya Sumiyoshi
Yuji Nagatomo
Toru Hosoda
Masatoshi Nagayama
Yuichi Ishikawa
Tomohiro Sawa
Satoshi Iimuro
Tsutomu Yoshikawa
Saichi Hosoda
Incidence of cancers in patients with atherosclerotic cardiovascular diseases
International Journal of Cardiology: Heart & Vasculature
Atherosclerotic cardiovascular diseases
Cancers
Mortality
The SHIP cohort study
title Incidence of cancers in patients with atherosclerotic cardiovascular diseases
title_full Incidence of cancers in patients with atherosclerotic cardiovascular diseases
title_fullStr Incidence of cancers in patients with atherosclerotic cardiovascular diseases
title_full_unstemmed Incidence of cancers in patients with atherosclerotic cardiovascular diseases
title_short Incidence of cancers in patients with atherosclerotic cardiovascular diseases
title_sort incidence of cancers in patients with atherosclerotic cardiovascular diseases
topic Atherosclerotic cardiovascular diseases
Cancers
Mortality
The SHIP cohort study
url http://www.sciencedirect.com/science/article/pii/S2352906717300453
work_keys_str_mv AT makotosuzuki incidenceofcancersinpatientswithatheroscleroticcardiovasculardiseases
AT hitonobutomoike incidenceofcancersinpatientswithatheroscleroticcardiovasculardiseases
AT tetsuyasumiyoshi incidenceofcancersinpatientswithatheroscleroticcardiovasculardiseases
AT yujinagatomo incidenceofcancersinpatientswithatheroscleroticcardiovasculardiseases
AT toruhosoda incidenceofcancersinpatientswithatheroscleroticcardiovasculardiseases
AT masatoshinagayama incidenceofcancersinpatientswithatheroscleroticcardiovasculardiseases
AT yuichiishikawa incidenceofcancersinpatientswithatheroscleroticcardiovasculardiseases
AT tomohirosawa incidenceofcancersinpatientswithatheroscleroticcardiovasculardiseases
AT satoshiiimuro incidenceofcancersinpatientswithatheroscleroticcardiovasculardiseases
AT tsutomuyoshikawa incidenceofcancersinpatientswithatheroscleroticcardiovasculardiseases
AT saichihosoda incidenceofcancersinpatientswithatheroscleroticcardiovasculardiseases